Intersect ENT Inc operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Intersect ENT Inc with three other
companies in this sector in the United States:
sales of $93.77 million
of which 80%
Anika Therapeutics Inc
Lemaitre Vascular, Inc.
Intersect ENT Inc reported sales of $109.14 million
December of 2019.
a very small
increase of 0.6%
versus 2018, when the company's sales were $108.47 million.
Sales at Intersect ENT Inc have increased during each of the previous five years
(and since 2014, sales have increased a total of 183%).